USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/18476
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPopova, Oxana-
dc.date.accessioned2021-11-12T07:59:58Z-
dc.date.available2021-11-12T07:59:58Z-
dc.date.issued2014-
dc.identifier.citationPOPOVA, Oxana. Mechanical ventilation associated pneumonia: the impact of hospital mobidity and mortality in the pacients with severe cranial and central nervous system injury. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 187.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/18476-
dc.descriptionState University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Republic of Moldovaen_US
dc.description.abstractIntroduction: Ventilator associated pneumonia is one of the most frequent complication in mechanically ventilated critical patients from developing countries. The impact on morbidity, mortality and general treatment costs is undeniable. Purpose and objectives: (1) To highlight the rate, risk factors, causative bacteria and their resistance to antibiotics, and (2) To estimate additional morbidity, mortality and treatment costs in patients with severe traumatic brain injury (STBI) with ventilator associate pneumonia (VAP). Materials and methods: Were included all mechanically ventilated for more than 48 hours patients with STBI (n=253), admitted in Intensive Care Unit of National Scientific and Practical Center of Emergency Medicine during 2012 year. Registered parameters were: patient’s comorbidities, potential risk factors for VAP, bacterial spectrum and resistance, and hospitalization costs. Results: Almost a half of STBI patients who were ventilated for more than 48 hours developed VAP. Thirty-seven percents of them had left ventricular hypertrophy, 22% - arterial hypertension, 22% - ischemic heart disease, 19% - hepatitis. Confirmed risk factors, that significantly increased VAP prevalence, were: hemodynamic instability, hypovolemia, severe bleeding, femur or tibia fracture, broken ribs, pleurisy, and pneumothorax. The bacterial agents causing VAP in study group where: Acinetobacter (25%), Pseudomonas aeruginosa (19%), Streptococcus epidermidis (17%), Proteus mirabilis (15%), Klebsiella pneumoniae (15%), Enterococcus faecalis (9%); all of them where antibiotic resistant. Length of stay in intensive care unit was: for STBI with VAP - 18 days vs. 12 days, in case of STBI without VAP. Hospitalization costs in VAP (+) group was three times higher. Registered extramorbidity in STBI patients with VAP was 22%. Conclusion: (1) VAP is caused by multi resistant to antibiotics nosocomial flora. (2) In STBI patients, VAP was associated with an important extra morbidity, extra mortality and costs of care. (3) Most of mentioned risk factors are manageable, so, VAP is a highly preventable nosology.en_US
dc.language.isoenen_US
dc.publisherMinistry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Associationen_US
dc.relation.ispartofMedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldovaen_US
dc.subjectsevere traumatic brain injuryen_US
dc.subjectventilator associated pneumoniaen_US
dc.subjectmortalityen_US
dc.titleMechanical ventilation associated pneumonia: the impact of hospital mobidity and mortality in the pacients with severe cranial and central nervous system injuryen_US
dc.typeOtheren_US
Appears in Collections:MedEspera 2014



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback